Anti-schizophrenia drug Cobenfy could treat Alzheimer's

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…

FDA Approves Eli Lilly's Zepbound Weight-Loss Drug for Sleep Apnea

An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York, U.S., on Thursday, March…